Latest Property News

Anson Resources has locked in a substantial $194 million business incentive from the Utah Inland Port Authority to support its Green River Lithium Project, underpinning the financing of its planned 10,000tpa lithium carbonate plant.

Immuron Limited has inked an exclusive US distribution deal for PROIBS®, a European-certified medical device targeting abdominal discomfort, marking a key step in its digestive health portfolio growth.

InFocus Group Holdings has secured $450,000 in a placement to fund the commercialisation of its AI-driven Codexa sweepstakes casino platform, targeting the US market with new compliance technology and patent applications.

4DS Memory Limited is raising nearly $3 million through a pro-rata entitlement issue as part of a broader $5 million capital raise to acquire AI software firm Jenesys and integrate it with its ReRAM technology.

Symal Group has received the green light to commence work on the $366 million Gawara Baya Wind Farm project in North Queensland, marking a notable expansion in its renewable energy footprint and Queensland presence.

Capstone Copper has boosted its Atacama presence by acquiring the San Pietro copper project, adding 16,000 hectares and nearly half a billion tonnes of inferred resources to its Mantoverde-Santo Domingo district.

RMA Global grew revenue 7% to $22.7 million in FY26, driven by US market gains and integration of Curated Social, but losses widened to $3.5 million. The company rebranded as Renowned and secured record US brokerage deals.

Nanoveu's EMASS division has been granted a US patent for a silicon accelerator that dramatically speeds up AI object detection, underpinning its next-gen ECS-DoT chip now in production at TSMC.

Eden Innovations Ltd trimmed its loss to $5 million in FY2026 while erasing bank debt and converting loans into equity, supported by property sales and capital raises.

Recce Pharmaceuticals narrowed its operating loss to AUD 15 million in FY26, progressing Phase 3 trials for its anti-infective RECCE 327 and securing key patents and commercial partnerships.

Microba Life Sciences delivered a mixed FY26, with overall revenue slipping 5.8% to $14.76 million and a statutory loss widening 38.7% to $20.7 million. The company’s strategic pivot to core microbiome testing paid off with a 92% surge in core testing revenue and record test volumes in Australia and the UK. Despite the headline loss, underlying loss improved 11% thanks to cost cuts and AI-driven efficiencies. Microba is gearing up for the October launch of its GI Navigator diagnostic and targeting cash flow break-even on a run-rate basis in calendar 2027.

Nimy Resources reports metallurgical tests achieving 84% gallium and up to 95% rare earth extraction at its Mons Project Block 3, underpinning proprietary processing technology and feeding into a scoping study.